Related Experiment Video
Updated: May 19, 2026

A Sensitive Visual Method for the Detection of Hydrogen Sulfide Producing Bacteria
Published on: June 27, 2022
Hypotensive effects of statins. A place for hydrogen sulfide in the puzzle?
Bogdan Wiliński1, Jerzy Wiliński, Eugeniusz Somogyi
1Zakład Biologii Rozwoju Człowieka, Wydział Nauk o Zdrowiu, Universytet Jagielloński Collegium Medicum, Kraków, Poland. bowil@interia.pl
Insights
Statins, used to lower cholesterol, may also reduce blood pressure. This review explores how atorvastatin increases hydrogen sulfide (H2S) levels in kidneys, potentially contributing to blood pressure reduction.
Area of Science:
- Cardiovascular Biology
- Nephrology
- Pharmacology
Background:
- 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, known as statins, are primary treatments for cardiovascular diseases.
- Clinical studies suggest statins can lower blood pressure, particularly in hypertensive patients.
- Pleiotropic effects of statins, beyond lipid-lowering, are increasingly recognized for their impact on cardiovascular health.
Purpose of the Study:
- To discuss the pleiotropic effects of statins influencing blood pressure.
- To present recent findings on the role of hydrogen sulfide (H2S) in cardiovascular and kidney function.
- To highlight atorvastatin's effect on kidney H2S concentration.
Main Methods:
- Review of clinical trial data on statins and blood pressure.
- Analysis of recent research on hydrogen sulfide (H2S) in cardiovascular and renal physiology.
- Focus on studies investigating atorvastatin's impact on tissue H2S levels.
Main Results:
- Statins significantly reduce cardiovascular morbidity and mortality.
- Evidence indicates statins possess blood pressure-lowering properties, especially in hypertensive individuals.
- Atorvastatin has been shown to increase hydrogen sulfide (H2S) tissue concentration in the kidneys.
Conclusions:
- Statins offer cardiovascular benefits and may contribute to blood pressure regulation.
- Hydrogen sulfide (H2S) plays a role in cardiovascular and kidney physiology.
- Atorvastatin's ability to increase renal H2S may represent a novel mechanism for its antihypertensive effects.
Abstract:
Lipid lowering 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors--statins--significantly diminish the risk of cardiovascular morbidity and mortality in patients with cardiovascular diseases. Moreover, some clinical trials results indicate that this group of drugs reduces blood pressure, especially in patients with hypertension. In the article pleiotropic effects of statins that might have influence on blood pressure are discussed. Recent data on the role of gaseous messenger hydrogen sulfide (H2S) in cardiovascular biology and kidney physiology are presented with the focus on the latest findings of atorvastatin increasing H2S tissue concentration in kidneys.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Antihypertensive Drugs: Thiazide-Class Diuretics
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Entropy and Solvation
Weak Acid Solutions
